Used in cancer research and therapy development, particularly targeting tumor cell migration and metastasis. It inhibits integrin-mediated signaling pathways involved in cell adhesion and motility, showing potential in blocking tumor progression in cancers such as pancreatic, ovarian, and prostate. Also employed as a reference standard in immunoassays and antibody development due to its well-characterized binding properties. Investigated for use in monoclonal antibody-based treatments and diagnostic tools for epithelial-derived tumors.